Additionally, the authors showed that their nanoparticle formulation, combined with CTLA-4 checkpoint blockade therapy and radiotherapy, could inhibit tumor metastases and provide long-term antitumor immunity effects when rechallenged by an additional tumor inoculation. This evidence concerns the gene CTLA4 and neoplasm.